Circ_0031242 Silencing Mitigates the Progression and Drug Resistance in DDP-Resistant Hepatoma Cells by the miR-924/POU3F2 Axis
Authors Fan W, Chen L, Wu X, Zhang T
Received 19 July 2020
Accepted for publication 26 December 2020
Published 26 January 2021 Volume 2021:13 Pages 743—755
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 6
Editor who approved publication: Dr Ahmet Emre Eşkazan
Wei Fan,1,* Lei Chen,2,* Xiaojuan Wu,3 Tong Zhang4
1Department of Hepatobiliary Surgery, The Third Affiliated Hospital of Shandong First Medical University (The Forth People’s Hospital of Jinan), Jinan 250031, Shandong, People’s Republic of China; 2Department of Emergency Medicine, Xiang’an Hospital of Xiamen University, Xiamen 361101, Fujian, People’s Republic of China; 3Department of Pharmacy, The First Affiliated Hospital of University of South China, Hengyang 421001, Hunan, People’s Republic of China; 4Department of Hepatobiliary Surgery, Xinghua City People’s Hospital, Xinghua 225700, Jiangsu, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Tong Zhang
Department of Hepatobiliary Surgery, Xinghua City People’s Hospital, No. 4 Jianxing Garden, Zhangyang North Village, Xinghua 225700, Jiangsu, People’s Republic of China
Background: Circular RNAs (circRNAs) have been implicated in the progression and chemoresistance development of hepatocellular carcinoma (HCC). However, the precise parts of circ_0031242 in HCC chemoresistance are still not fully understood.
Methods: The levels of circ_0031242, miR-924 and POU class 3 homeobox 2 (POU3F2) were detected by quantitative real-time polymerase chain reaction (qRT-PCR) assay or Western blot analysis. IC50 value for cisplatin (DDP) and cell viability were measured by the cell counting kit-8 (CCK-8) assay. Cell migration, invasion and apoptosis were assessed by transwell assay and flow cytometry, respectively. Targeted correlations among circ_0031242, miR-924 and POU3F2 were verified by the dual-luciferase reporter and RNA immunoprecipitation (RIP) assays.
Results: Our data revealed that circ_0031242 was associated with HCC resistance to DDP. The silencing of circ_0031242 diminished DDP resistance, suppressed cell viability, migration, invasion and promoted apoptosis of DDP-resistant HCC cells (Huh7-R and SNU-387-R) in vitro, as well as enhanced DDP sensitivity in vivo. Mechanistically, circ_0031242 directly interacted with miR-924 by binding to miR-924. Moreover, miR-924 was a downstream effector of circ_0031242 function. POU3F2 was a direct target of miR-924, and miR-924 overexpression regulated DDP-resistant HCC cell progression and DDP resistance by down-regulating POU3F2. Furthermore, circ_0031242 modulated POU3F2 expression through sponging miR-924.
Conclusion: Our findings identified that circ_0031242 functioned as an important regulator in DDP-resistant HCC cell progression and DDP resistance through the miR-924/POU3F2 axis, illuminating circ_0031242 as a potential therapeutic target for the chemoresistant HCC.
Keywords: HCC, chemoresistance, circ_0031242, miR-924, POU3F2
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]